We participate in numerous events promoting our portfolio companies and meeting our clients.

2012

Ahram Biosystems makes a new polymerase chain reaction (PCR) device that provides fast, sensitive and reliable amplification of nucleic acid in a battery operated, handheld format. The device (called Palm PCR™) is portable and designed to allow users to perform PCR nearly anywhere. Palm PCR™ was recently featured in a major science textbook for US college students (Human Genetics and Society, Cengage Learning, see cover) in a chapter describing PCR applications in the field of DNA forensics. Ahram’s Palm PCR™ also received a favorable product review in Science Magazine (7 October, 2011). For more information, see www.ahrambio.com.

Ventac Partners has provided strategic business and patent portfolio development advice to Aharm since 2006.

CASiGEN Pharma Ltd, a new portfolio company of Ventac Partners, is a Hong Kong based company focusing on the development of novel therapeutic compounds for metabolic disease indications.

Avexxin, a Ventac Partners portfolio company, is closing series A financing round enabling the company to take its lead compound forward through clinical trial phase I/IIa. Open PRESS RELEASE.

Subscribe to our Newsletter

Thank you!